שווי כולל של החברה: Telomir Pharmaceuticals (TELO)

The market price action for Telomir Pharmaceuticals (TELO) visualized on GURU.Markets illustrates the dynamics of a brand focused on tissue regeneration and anti-aging. The enterprise value stands at 65.95, with production outsourced to third-party contractors to minimize technical risks. The market is showing significant hype surrounding innovative telomere lengthening methods, which strengthens the company's authority within the scientific community.

Telomir Pharmaceuticals (TELO) is implementing green chemistry and bioethics principles into the development of anti-aging therapies. The enterprise value aggregates market capitalization and debt, subtracting cash to determine the total acquisition price of the business. For the investor, this metric reveals the actual value of assets accounting for all liabilities. This analysis allows for an assessment of the efficiency of capital investments in sustainable biotechnologies. The price action of the company's real market value reflects its fundamental stability.